Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'neuropeptide y 13 36 porcine'

Search results for: 'neuropeptide y 13 36 porcine'

Items 31-40 of 52

Page
per page
  1. Marimastat
    A4049 Marimastat
     1 Citation
    Target: MMP
    Summary: MMPs inhibitor,board spectrum
      ≥2.8 mg/mL
  2. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL
  3. MDV3100 (Enzalutamide)
    A3003 MDV3100 (Enzalutamide)
     12 Citation
    Target: Androgen Receptors
    Summary: Androgen receptor antagonist
      ≥23.22 mg/mL
  4. Agouti-related Protein (AGRP) (25-82), human
    A1134 Agouti-related Protein (AGRP) (25-82), human
    Target: Melanocortin (MC) Receptors
    Summary: Agouti-related peptide(25-82)
      insoluble in EtOH; insoluble in DMSO; ≥100 mg/mL
  5. WAY 170523
    A4442 WAY 170523
    Target: MMP
    Summary: MMP-13 inhibitor,potent and selective
      <61.37 mg/mL
  6. XL147
    A5112 XL147
    Target: PI3K
    Summary: PI3K inhibitor,selective and reversible
      ≥22.45 mg/mL
  7. Romidepsin (FK228, depsipeptide)
    A8173 Romidepsin (FK228, depsipeptide)
     7 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC1/HDAC2 inhibitor, potent and selective
      ≥27.04 mg/mL
  8. Lenalidomide (CC-5013)
    A4211 Lenalidomide (CC-5013)
    Target: angiogenesis
    Summary: Antineoplastic agent,inhibits angiogenesis
      insoluble in EtOH; insoluble in H2O; ≥100.8 mg/mL
  9. Pomalidomide (CC-4047)
    A4212 Pomalidomide (CC-4047)
    Summary: Immunomodulator,antumor/anti-angiogenic
      insoluble in EtOH; insoluble in H2O; ≥7.5 mg/mL
  10. NU 9056
    A4492 NU 9056
    Target: Histone Acetyltransferases (HATs)
    Summary: KAT5 (Tip60) HAT inhibitor
      <10 mg/mL

Items 31-40 of 52

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Lab Reagents 1 item
Reversibility
  1. Reversible 3item
Target
  1. Histone Deacetylases (HDACs) 2item
  2. Akt 1 item
  3. PI3K 5item
  4. CXCR 1 item
  5. Raf 2item
  6. Aurora Kinases 3item
  7. mTOR 2item
  8. MMP 3item
  9. Androgen Receptors 1 item
  10. FLT3 2item
  11. LPA Receptors 1 item
  12. P-glycoprotein (P-gp) 1 item
  13. PLK 1 item
  14. ULK1 1 item
  15. Eph Receptors 1 item
  16. VEGFR 4item
  17. PDGFR 4item
  18. c-Kit 2item
  19. RET 1 item
  20. Phosphodiesterases (PDEs) 1 item
  21. Bcr-Abl 2item
  22. FGFR 2item
  23. Voltage-gated Sodium (NaV) Channels 2item
  24. Src 1 item
  25. ROCK 2item
  26. PAK 1 item
  27. p300 1 item
  28. DNA-PK 3item
  29. HSP90 1 item
  30. eIF4E/eIF3G interaction 1 item
  31. RAD51 1 item
  32. LRRK2 1 item
  33. Voltage-gated Calcium Channels (CaV) 1 item
  34. Melanocortin (MC) Receptors 1 item
  35. HIV-1 gp120 1 item
  36. Glutamate (Metabotropic) Group I Receptors 1 item
  37. Synthases/Synthetases 1 item
  38. NPY Receptors 1 item
  39. Na /K ATPases 1 item
  40. P110 1 item
  41. Hck 1 item
  42. Catechol O-Methyltransferase (COMT) 1 item
  43. angiogenesis 1 item
  44. Histone Acetyltransferases (HATs) 1 item
  45. NOD1 1 item
  46. DCLK2 1 item
  47. gp120/CD4 1 item
  48. ATM 1 item
Reported Experiments
  1. Animal Experiments 41item
  2. Cell Experiments 34item
Related Disease
  1. Adrenocortical Carcinoma 1 item
  2. Bladder Cancer 1 item
  3. Brain Injuries Studies 1 item
  4. Breast Cancer 5item
  5. Cancer 30item
  6. Chronic Lymphocytic Leukemia 2item
  7. Chronic Myeloproliferative Disorders 1 item
  8. Clear Cell Renal Cell Carcinoma 1 item
  9. Cocaine-Related Disorders 1 item
  10. Colon Cancer 2item
  11. Colorectal Cancer 3item
  12. Glioblastoma 3item
  13. Glioma 3item
  14. HIV 2item
  15. Leukemia 3item
  16. Lung Cancer 4item
  17. Lymphoma 1 item
  18. Melanoma 1 item
  19. Multiple Myeloma 3item
  20. Myelofibrosis 1 item
  21. Neuroblastoma 3item
  22. Neurocognitive Disorders 1 item
  23. Non-small Cell Lung Carcinoma 1 item
  24. Obsessive-Compulsive Disorder 1 item
  25. Osteoporosis 1 item
  26. Ovarian Cancer 2item
  27. Pancreatic Cancer 3item
  28. Prostate Cancer 4item
  29. Pulmonary Fibrosis 1 item
  30. Renal Cancer 1 item
  31. Schizophrenia 1 item
  32. Soft Tissue Sarcoma 1 item
  33. Thyroid Cancer 1 item